the active ingredient in a drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis. it is also used to prevent and treat osteoporosis in postmenopausal women. it is also being studied in the prevention of breast cancer in certain premenopausal women and in the prevention and treatment of other conditions. raloxifene blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. it is a type of selective estrogen receptor modulator (serm).
出典:Wiktionary
出典:『Wiktionary』 (2025/03/14 21:35 UTC 版)
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.) From ral- (of unknown origin) + -oxifene (“tamoxifen derivative”).
raloxifene (uncountable)
出典:Wikipedia
出典:『Wikipedia』 (2011/04/10 20:21 UTC 版)
Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.